NEWS & EVENTS:

> Fierce Biotech names Intarcia Therapeutics as one of the "Fierce 15"  BioTech Companies of 2007  

> Intarcia Announces Presentation of final results from a Phase 2 Combination Study for Treatment of Hepatitis C at Digestive Disease Week Conference